Annual Total Long Term Liabilities
$6.30 M
+$303.00 K+5.05%
31 December 2023
Summary:
Lumos Pharma annual total long term liabilities is currently $6.30 million, with the most recent change of +$303.00 thousand (+5.05%) on 31 December 2023. During the last 3 years, it has risen by +$98.00 thousand (+1.58%).LUMO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$6.04 M
-$103.00 K-1.68%
30 September 2024
Summary:
Lumos Pharma quarterly total long term liabilities is currently $6.04 million, with the most recent change of -$103.00 thousand (-1.68%) on 30 September 2024. Over the past year, it has dropped by -$261.00 thousand (-4.14%).LUMO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -4.1% |
| 3 y3 years | +1.6% | -2.6% |
| 5 y5 years | -90.1% | -90.5% |
LUMO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -90.8% | -92.1% |
Lumos Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.04 M(-1.7%) |
| June 2024 | - | $6.14 M(-1.3%) |
| Mar 2024 | - | $6.22 M(-1.2%) |
| Dec 2023 | $6.30 M(+5.1%) | $6.30 M(+2.6%) |
| Sept 2023 | - | $6.14 M(-0.4%) |
| June 2023 | - | $6.17 M(-0.4%) |
| Mar 2023 | - | $6.19 M(+3.1%) |
| Dec 2022 | $6.00 M(-3.3%) | $6.00 M(-0.3%) |
| Sept 2022 | - | $6.02 M(-0.9%) |
| June 2022 | - | $6.08 M(-0.9%) |
| Mar 2022 | - | $6.13 M(-1.2%) |
| Dec 2021 | $6.21 M(+3.4%) | $6.21 M(-1.3%) |
| Sept 2021 | - | $6.29 M(-1.3%) |
| June 2021 | - | $6.37 M(+4.3%) |
| Mar 2021 | - | $6.11 M(+1.8%) |
| Dec 2020 | $6.00 M(-90.6%) | $6.00 M(-43.9%) |
| Sept 2020 | - | $10.69 M(-18.9%) |
| June 2020 | - | $13.17 M(-10.1%) |
| Mar 2020 | - | $14.65 M(-77.0%) |
| Dec 2019 | $63.73 M(+817.1%) | $63.73 M(+925.0%) |
| Sept 2019 | - | $6.22 M(-53.9%) |
| June 2019 | - | $13.50 M(+0.9%) |
| Mar 2019 | - | $13.38 M(+92.5%) |
| Dec 2018 | $6.95 M(-2.3%) | $6.95 M(-0.6%) |
| Sept 2018 | - | $6.99 M(-0.5%) |
| June 2018 | - | $7.03 M(-0.6%) |
| Mar 2018 | - | $7.07 M(-0.6%) |
| Dec 2017 | $7.11 M | $7.11 M(-0.7%) |
| Sept 2017 | - | $7.16 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $7.22 M(-1.1%) |
| Mar 2017 | - | $7.30 M(-1.1%) |
| Dec 2016 | $7.38 M(-7.0%) | $7.38 M(-0.6%) |
| Sept 2016 | - | $7.42 M(-1.8%) |
| June 2016 | - | $7.56 M(-3.1%) |
| Mar 2016 | - | $7.80 M(-1.6%) |
| Dec 2015 | $7.93 M(-14.4%) | $7.93 M(-3.2%) |
| Sept 2015 | - | $8.19 M(-3.1%) |
| June 2015 | - | $8.46 M(-3.2%) |
| Mar 2015 | - | $8.73 M(-5.7%) |
| Dec 2014 | $9.26 M(+10.9%) | $9.26 M(+12.3%) |
| Sept 2014 | - | $8.25 M(+0.4%) |
| June 2014 | - | $8.22 M(-0.8%) |
| Mar 2014 | - | $8.29 M(-0.8%) |
| Dec 2013 | $8.35 M(-2.7%) | $8.35 M(-0.8%) |
| Sept 2013 | - | $8.42 M(-0.8%) |
| June 2013 | - | $8.49 M(-0.3%) |
| Mar 2013 | - | $8.52 M(-0.7%) |
| Dec 2012 | $8.58 M(+811.1%) | $8.58 M(-0.6%) |
| Sept 2012 | - | $8.63 M(+4.2%) |
| June 2012 | - | $8.29 M(-0.6%) |
| Mar 2012 | - | $8.34 M(+785.2%) |
| Dec 2011 | $942.00 K(-98.6%) | $942.00 K(-98.8%) |
| Sept 2011 | - | $76.26 M(+7197.8%) |
| June 2011 | - | $1.04 M(-98.5%) |
| Dec 2010 | $68.83 M(+14.3%) | $68.83 M(+24.5%) |
| Sept 2010 | - | $55.27 M(-8.2%) |
| Dec 2009 | $60.21 M(+48.5%) | $60.21 M |
| Dec 2008 | $40.56 M | - |
FAQ
- What is Lumos Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Lumos Pharma?
- What is Lumos Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Lumos Pharma?
- What is Lumos Pharma quarterly long term liabilities year-on-year change?
What is Lumos Pharma annual total long term liabilities?
The current annual total long term liabilities of LUMO is $6.30 M
What is the all time high annual total long term liabilities for Lumos Pharma?
Lumos Pharma all-time high annual total long term liabilities is $68.83 M
What is Lumos Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of LUMO is $6.04 M
What is the all time high quarterly long term liabilities for Lumos Pharma?
Lumos Pharma all-time high quarterly total long term liabilities is $76.26 M
What is Lumos Pharma quarterly long term liabilities year-on-year change?
Over the past year, LUMO quarterly total long term liabilities has changed by -$261.00 K (-4.14%)